Brief: TELA Bio Q2 Revenue USD 16.091 Million Vs. IBES Estimate USD 18.5 Million
12/08/2024 21:05
Aug 12 (Reuters) - TELA Bio Q2 basic EPS USD -0.51. * Q2 net income USD -12.6 million * Q2 income from operations USD -11.57 million * Q2 gross profit USD 11.073 million * Q2 operating expenses USD 22.643 million * outlook FY revenue USD 74.5-76.5 million
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants